CARE Ratings Ltd Technical Momentum Shifts to Sideways Amid Mixed Indicator Signals

Price Movement and Market Context

On 13 Feb 2026, CARE Ratings closed at ₹1,625.25, marking a 1.55% increase from the previous close of ₹1,600.40. The stock traded within a range of ₹1,600.50 to ₹1,686.35 during the day, demonstrating intraday volatility but ultimately closing near the upper end of the range. Despite this positive daily movement, the stock remains below its 52-week high of ₹1,964.80, indicating room for further upside potential. The 52-week low stands at ₹1,057.65, underscoring the stock’s significant appreciation over the past year.

Technical Trend Evolution

The technical trend for CARE Ratings has transitioned from mildly bearish to sideways, suggesting a period of consolidation after recent declines. This shift is corroborated by mixed signals from various technical indicators, which paint a picture of cautious investor sentiment.

MACD Analysis

The Moving Average Convergence Divergence (MACD) indicator presents a dichotomy in its weekly and monthly readings. On the weekly chart, the MACD is bullish, signalling upward momentum in the short term. Conversely, the monthly MACD remains mildly bearish, indicating that longer-term momentum has yet to fully recover. This divergence suggests that while short-term traders may find opportunities, longer-term investors should remain vigilant for confirmation of sustained strength.

RSI and Momentum Indicators

The Relative Strength Index (RSI) on both weekly and monthly timeframes currently shows no definitive signal, hovering in neutral territory. This lack of extreme readings implies that the stock is neither overbought nor oversold, consistent with the sideways trend. Meanwhile, the Know Sure Thing (KST) indicator aligns with the MACD, showing bullish momentum on the weekly scale but mildly bearish on the monthly, reinforcing the mixed momentum narrative.

Bollinger Bands and Moving Averages

Bollinger Bands provide further insight, with the weekly bands indicating a mildly bullish stance and the monthly bands confirming a bullish trend. This suggests that price volatility is contained within an upward channel in the medium term. However, daily moving averages remain mildly bearish, reflecting recent price softness and signalling potential resistance levels that the stock must overcome to sustain gains.

Volume and On-Balance Volume (OBV)

Volume analysis via the On-Balance Volume (OBV) indicator reveals a mildly bearish trend on the weekly chart but a bullish trend on the monthly chart. This divergence indicates that while short-term volume flow may be subdued, longer-term accumulation is occurring, which could support future price appreciation if buying interest intensifies.

Dow Theory and Broader Market Comparison

According to Dow Theory, there is no clear trend on either the weekly or monthly charts, reinforcing the sideways consolidation view. When compared to the broader market, CARE Ratings has outperformed the Sensex significantly over longer horizons. The stock’s one-year return stands at 34.76%, compared to the Sensex’s 9.85%, while its three-year and five-year returns are 159.77% and 236.87%, respectively, dwarfing the Sensex’s 37.89% and 62.34% returns. However, short-term returns over one week and one month have been negative, at -1.34% and -1.64%, respectively, while the Sensex posted modest gains in the same periods.

Mojo Score and Rating Upgrade

CARE Ratings currently holds a Mojo Score of 54.0, placing it in the Hold category, an upgrade from its previous Sell rating as of 10 Feb 2026. This improvement reflects a more balanced outlook on the stock’s prospects, factoring in the recent technical momentum shift and fundamental considerations. The Market Cap Grade remains modest at 3, indicating a mid-sized market capitalisation relative to peers in the capital markets sector.

Implications for Investors

The mixed technical signals suggest that investors should approach CARE Ratings with a measured stance. The bullish weekly MACD and Bollinger Bands indicate potential for short-term gains, but the mildly bearish monthly MACD and daily moving averages counsel caution. The sideways trend implies that the stock may consolidate before making a decisive move, and volume patterns hint at underlying accumulation that could fuel a breakout.

Given the stock’s strong long-term performance relative to the Sensex, investors with a medium to long-term horizon may find value in accumulating on dips, while short-term traders should monitor key technical levels closely. The absence of extreme RSI readings reduces the risk of immediate sharp reversals, but the lack of a clear Dow Theory trend means confirmation from price action is essential before committing significant capital.

Sector and Industry Context

Operating within the capital markets sector, CARE Ratings faces sector-specific headwinds and opportunities. The capital markets industry has experienced volatility amid shifting economic conditions and regulatory changes, which have influenced investor sentiment and trading volumes. CARE Ratings’ ability to maintain a Hold rating amidst these challenges underscores its relative resilience and the market’s recognition of its stable fundamentals.

Conclusion: Navigating the Technical Landscape

CARE Ratings Ltd’s recent technical parameter changes reflect a stock in transition, balancing between bearish pressures and emerging bullish momentum. The upgrade in Mojo Grade to Hold aligns with this technical evolution, signalling a more neutral stance from analysts and investors alike. While short-term indicators offer some optimism, longer-term signals advise prudence.

Investors should closely monitor the stock’s ability to break above resistance levels near ₹1,686 and sustain above daily moving averages to confirm a bullish reversal. Conversely, a drop below recent lows near ₹1,600 could reintroduce bearish momentum. The stock’s impressive long-term returns relative to the Sensex provide a compelling backdrop for patient investors willing to navigate the current consolidation phase.

Overall, CARE Ratings presents a nuanced technical picture that rewards careful analysis and disciplined trading strategies, making it a stock to watch closely in the capital markets space.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →